G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Director – Scientific Communications

Technical WritingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • At least 12 years of experience with a Bachelor of Science or Bachelor of Arts degree.
  • At least 10 years of experience with a Master of Science or Master of Arts degree.
  • At least 8 years of experience with a PhD or PharmD degree.

Responsibilities

  • Define, own, and proactively refresh an integrated publication strategy across assets, disease areas, and lifecycle stages, balancing launch, lifecycle-management, and pipeline priorities.
  • Own the scientific platform and ensure consistent, differentiated narratives across publications, congress disclosures, and related deliverables.
  • Integrate asset positioning, evidence assessment, external insights, and the evolving treatment landscape into publication strategy.
  • Identify evidence and communication gaps and partner with Medical Affairs, Clinical Development, Biostatistics, Strategy, and other functions to address them.
  • Lead portfolio strategy and sequencing for high-impact clinical, real-world, translational, and other scientific publications and data disclosures.
  • Determine the recommended congress, encore, and downstream externalization approach across the portfolio, anticipating scientific, operational, and compliance risks and dependencies.
  • Prioritize publication investment and vendor capacity across competing needs and make cross-asset trade-off recommendations when timing, positioning, budget, or resources conflict.
  • Decide which activities should be initiated, accelerated, combined, deferred, or discontinued within the approved strategy and budget, escalating only matters requiring governance approval.
  • Bring governance-ready recommendations that clearly explain the scientific rationale, options, implications, and risks.
  • Serve as the principal Publications adviser across Programme Teams, Global Brand Teams, evidence-generation forums, and senior governance bodies.
  • Lead complex cross-functional discussions, constructively challenge assumptions, and drive alignment and decisions without formal authority.
  • Own portfolio publication budget planning, resource allocation, vendor strategy, capacity planning, and performance oversight.
  • Ensure publication activities meet applicable scientific, authorship, ethical, legal, compliance, and company standards, including Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) principles.
  • Create inclusion by modeling inclusion and embedding the value of diversity in how teams are managed.
  • Develop talent by understanding employees’ skills, experience, aspirations, and potential and coaching them on current performance and future potential; ensure they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding teams accountable, removing barriers, and connecting teams to the broader organization.

Desired Qualifications

  • At least 8 years of scientific or medical publications experience in the biotechnology or pharmaceutical industry, including significant hematology/oncology and/or cell therapy experience.
  • Demonstrated ability to set publication priorities, resolve complex planning issues, and make sound recommendations with incomplete or evolving data.
  • Proven ability to lead cross-functional teams, influence senior stakeholders and external experts, facilitate discussion, and resolve differences without direct authority.
  • Strong working knowledge of Medical Affairs, Clinical Development, Legal, Intellectual Property, and other functions affected by Publications.
  • Strong commitment to publication ethics and knowledge of relevant guidelines, laws, industry standards, and corporate policies, including Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) principles.
  • Ability to travel up to 15%, including weekends.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs